Shareholder Class Action Filed Against Discovery Laboratories, Inc. by the Law Firm of Schiffrin & Barroway, LLP
Yahoo! News (press release) - 8 hours ago  
Throughout the Class Period , Discovery repeatedly asserted that it anticipated that Surfaxin would receive US regulatory approval in April 2006. On April 24 , 2006 , Discovery announced that ...
Law Offices of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Discovery Laboratories, Inc.
Market Wire (press release) - 4 May 2006  
The class action lawsuit was filed in the United States District Court for the Eastern District of Pennsylvania.
Law Offices Of Charles J. Piven, PA Announces Class Action Lawsuit Against Discovery Laboratories, Inc.
Market Wire (press release) - 3 May 2006  
CONTACT : Law Offices Of Charles J . Piven , PA , Baltimore , Maryland Charles J . Piven 410 / 986 - 0036 Email Contact
Schatz & Nobel, PC Announces Class Action Lawsuit Against Discovery Laboratories, Inc. -- DSCO
PrimeZone (press release) - 2 May 2006  
Throughout the Class Period , defendants repeatedly represented that they anticipated FDA approval of Surfaxin in April 2006. On April 25 , 2006 , Discovery revealed that Surfaxin's " stability ...
The Law Firm of Goldman Scarlato & Karon, PC Announces Class Action Lawsuit Against Discovery Laboratories, Inc. - Business Wire (press release)
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Discovery Laboratories, Inc. - Yahoo! News (press release)
PR Newswire (press release)   PrimeZone (press release)  
Discovery Laboratories downgraded to "sell"
newratings.com - 26 Apr 2006  
NEW YORK , April 26 ( newratings . com ) - Analyst Y Katherine Xu of Pacific Growth Equities downgrades Discovery Laboratories Inc ( DSCO. NAS ) from " buy " to " sell . "
Discovery Laboratories Is Trading Lower On Surfaxin News
Trading Markets - 25 Apr 2006  
Surfaxin is being developed for the prevention of Respiratory Distress Syndrome in premature infants. The news follows analysis of ongoing stability data from Surfaxin process validation batches ...
Discovery Laboratories - UPDATE - Losing Ground On FDA News
Trading Markets - 5 Apr 2006  
The FDA is requesting certain information primarily focused on the chemistry , manufacturing and controls section of the company's new drug application. The stock is now down 1.59 on 8K shares ...
Discovery Laboratories Inc. Is Pulling Back On Phase 2 Results
Trading Markets - 31 Mar 2006  
Discovery Laboratories traded in a range for the majority of Thursday's session and closed unchanged at $7.64. The stock closed testing the lower end of a one - month range.
Discovery Laboratories initiated with "buy"
newratings.com - 23 Mar 2006  
NEW YORK , March 23 ( newratings . com ) - Analyst Y Katherine Xu of Pacific Growth Equities initiates coverage of Discovery Laboratories Inc ( DSCO. NAS ) with a " buy " rating.
FDA Grants Discovery Laboratories, Inc.' Surfaxin Fast Track Designation for Prevention and Treatment of Bronchopulmonary Dysplasia
Reuters Key Development - 26 Jan 2006